Results 1 to 10 of about 87,239 (208)

The effects of neoadjuvant chemoradiotherapy-related frailty by analytic morphomics in esophageal cancer [PDF]

Journal of Cardiothoracic Surgery
Background Neoadjuvant chemoradiotherapy followed by surgery offers potential cure for locally advanced esophageal cancer. Yet, frailty often emerges post-therapy, heightening risks of delayed surgery and complications.
Chien-Hung Chiu, Jules Lin, Peng Zhang, Andrew C. Chang, Brian A. Derstine, Brian E Ross, Binu Enchakalody, Nidhi V. Shah, Yun-Hen Liu, Stewart C. Wang, Yin-Kai Chao   +10 more
doaj   +2 more sources

Outcome of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in non-metastatic locally advanced non-small cell lung cancer – A prospective and randomized study

Asian Journal of Medical Sciences, 2023
Background: Sequential chemoradiotherapy and concurrent chemoradiotherapy are two treatment options for locally advanced non-small cell lung cancer (NSCLC). Still there is limited data regarding which is the better treatment option.
Subir Pal , Anjan Bera , Soumen Mukherjee , Asmita Dasgupta , Srikrishna Mandal , Saptarshi Banerjee   +5 more
doaj   +3 more sources

Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer [PDF]

Radiation Oncology, 2011
Background To assess the clinical outcome of chemoradiotherapy with or without surgery for locally recurrent rectal cancer (LRRC) and to find useful and significant prognostic factors for a clinical situation.
Oh Jae Hwan, Choi Hyo Seong, Park Ji Won, Kim Sun Young, Kim Dae Yong, Lee Joo Ho, Chang Hee Jin, Kim Tae Hyun, Park Suk Won   +8 more
doaj   +2 more sources

Definitive chemoradiotherapy [PDF]

Journal of Thoracic Disease, 2017
Definitive chemoradiotherapy (dCRT) is reflecting a treatment standard in oesophageal cancer. For irresectable localised tumours and for inoperable patients, dCRT can change the treatment intent from palliative to curative. In patients with squamous cell carcinoma (SCC), in particular in those of cervical location, dCRT is a proper alternative for ...
Stahl, Michael, Budach, Wilfried
openaire   +2 more sources

Deficits in ascending pain modulation pathways in breast cancer survivors with chronic neuropathic pain: A resting-state fMRI study

Frontiers in Neurology, 2022
PurposeBreast cancer (BC) is the highest frequent malignancy in women globally. Approximately 25–60% of BC patients with chronic neuropathic pain (CNP) result from advances in treating BC. Since the CNP mechanism is unclear, the various treatment methods
Rui Liu, Na Qiao, Na Qiao, Shuwei Shi, Suyao Li, Yingman Wang, Jie Song, Wenting Jia   +7 more
doaj   +1 more source

Clinical Observation of Apatinib in Treatment of Refractory Advanced Breast Cancer

Zhongliu Fangzhi Yanjiu, 2020
Objective To evaluate the clinical efficacy and safety of apatinib in the treatment of advanced breast cancer(ABC) patients refractory to multiline treatments.
WANG Jing, JIA Jinghao, LIU Jingjing, CUI Zhichao, XIONG Wei, WANG Xiaohong   +5 more
doaj   +1 more source

Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.

PLoS ONE, 2022
IntroductionThe purpose of the current study is to compare definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with cT1-3/N0-3 esophageal squamous cell carcinoma in survival.MethodsRecords from 2008 to 2014 of 4931 ...
Yi-Lin Chang, Ya-Fu Cheng, Hui-Shan Chen, Siao-Chi Wu, Wei-Heng Hung, Heng-Chung Chen, Chang-Lun Huang, Ching-Yuan Cheng, Bing-Yen Wang   +8 more
doaj   +2 more sources

Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer [PDF]

Cochrane Database of Systematic Reviews, 2013
Please see Appendix 4 for a glossary of terms.The outcome of patients with esophageal cancer is generally poor. Although multimodal therapy is standard, there is conflicting evidence regarding the addition of esophagectomy to chemoradiotherapy.To compare the effectiveness and safety of chemoradiotherapy plus surgery with that of chemoradiotherapy alone
Balamurugan A, Vellayappan, Yu Yang, Soon, Geoffrey Y, Ku, Cheng Nang, Leong, Jiade J, Lu, Jeremy Cs, Tey   +5 more
openaire   +2 more sources

Identification of prognostic alternative splicing signature in gastric cancer

Archives of Public Health, 2022
Background Aberrant alternative splicing (AS) events could be viewed as prognostic indicators in a large number of malignancies. This study aims to identify prognostic AS events, illuminate the function of the splicing variants biomarkers and provide ...
Zhiwu Wang, Qiong Wu, Yankun Liu, Qingke Li, Jingwu Li   +4 more
doaj   +1 more source

Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma

Frontiers in Genetics, 2022
Background: Hepatocellular carcinoma (HCC) is a malignancy with a poor prognosis. This study aimed to distinguish patients with HCC having distinct tumour immune microenvironment (TIME) features and construct an immune-related gene signature (IRGs) to ...
Liangliang Wang, Liangliang Wang, Li Wang, Peihong He   +3 more
doaj   +1 more source